Navigation Links
LIGHTSHIFT EMSA Kit from Pierce Biotechnology, Inc.

ProductsLIGHTSHIFT EMSA Kit from Pierce Biotechnology, Inc.
Company Pierce Biotechnology, Inc.
Item LIGHTSHIFT EMSA Kit
Price 
Description The electrophoretic mobility shift assay (EMSA) is a powerful tool for evaluating DNA-protein interactions. Often referred to as gel shift or gel retardation, the assay is based on the principle that when subjected to electrophoresis, free DNA will migrate differently than a DNA-protein complex. The Pierce LightShift Chemiluminescent EMSA Kit is a nonradioactive system for performing EMSA using Pierce's proprietary chemiluminescent detection technology. Biotin-labeled DNA can be prepared using the Pierce Biotin 3’ End DNA Labeling Kit (Product# 89818) or ordered directly from your custom oligo supplier. Capable of sub-femtomole detection levels, the LightShift Chemiluminscent EMSA Kit offers the sensitivity and speed of radioactive assays without the hazards, waste and probe instability problems associated with radioactive systems. It comes with all necessary components, except positively charged nylon membrane, for performing 100 DNA-protein binding reactions and sufficient chemiluminescent detection reagents for 800 cm2 of membrane. A detailed protocol for optimizing EMSAs as well as a troubleshooting guide are also provided.
Features
  • Nonisotopic system no hazardous radioactive materials or waste
  • High sensitivity/low background noise the LightShift EMSA Kit is capable of sub-femtomole detection equivalent to radioactive EMSA systems
  • One day assay go from probe labeling to EMSA data analysis in a single day
  • Stable probes unlike radiolabeled probes biotin labeled probes are stable for more than one year
  • Biotin labeling kit sold separately customer can end-label DNA probes using the Pierce Biotin 3' End DNA Labeling Kit or order pre-labeled oligos from custom oligo suppliers
Sensitive, fast and non-radioactive electrophoretic mobility shift assays
Info Pierce Biotechnology, Inc.Pierce Biotechnology, Inc.
Pierce Biotechnology, Inc.
3747 N. Meridian Rd.
P.O. Box 117
Rockford, IL 61105
Customer Service: 815-968-0747
Fax Number: 815-968-8148
Web Site: http://www.piercenet.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Modern Protein Chemistry: Practical Aspects from Pierce Biotechnology, Inc.
2. Protein-Protein Interactions, from Pierce Biotechnology, Inc.
3. Imject Freunds Complete Adjuvant (FCA) from Pierce Biotechnology, Inc.
4. Imject Freunds Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
5. Extracti-Gel D Detergent Removing Gel AffinityPak Columns from Pierce Biotechnology, Inc.
6. GUIDE TO PROTEIN PURIFICA from Pierce Biotechnology, Inc.
7. PROTEIN PROTOCOLS Book from Pierce Biotechnology, Inc.
8. Product Information Request - SuperSignal West Pico COMPLETE Biotinylated Protein Detection Kit from Pierce Biotechnology, Inc.
9. UltraLink Immobilized NeutrAvidin from Pierce Biotechnology, Inc.
10. DISCOVERLIGHT RABBIT ARRA from Pierce Biotechnology, Inc.
11. PATH Protein Microarray Kit from Pierce Biotechnology, Inc.
... stem cells (HSC) are well-characterized tissue-specific stem ... are responsible for the life-long maintenance of ... that reside in adult bone marrow where ... also be found in cord blood, fetal ...
... Rabbit polyclonal to Atrophin 1 ( ... Antigen: Synthetic peptide conjugated ... to the C-terminus of Human Atrophin 1.(Note: ... as ab32861 .) ...
NNT-1/BSF-3 (N-14)...
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
Biology Products:
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International ... has released a new series of digital telemetry ... toxicology researchers. M series, part of the PhysioTel™ ... the best possible physiologic data when incorporating functional ... functional endpoints to toxicology studies has evolved from ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Many ancient crustaceans went extinct following a massive collapse of ... suggests modern species living in rapidly declining reef habitats may ... appear in the November issue of Geology , the ... reefs and the number of decapod crustaceans, a group that ...
... exhaust particles from traffic pollution leads to increased asthma ... this is due to increased blood levels of IL-17A, ... children with high diesel exposure. , The study by ... online in the Journal of Allergy and Clinical ...
... of the American Association of Feline Practitioners (AAFP) ... patients based on risk assessment., From ... The American Association of Feline Practitioners, (AAFP) ... updated guidelines on appropriate feline vaccination schedules based ...
Cached Biology News:Fossil record shows crustaceans vulnerable as modern coral reefs decline 2Fossil record shows crustaceans vulnerable as modern coral reefs decline 3Appropriate vaccinations schedules for feline patients outlined 2
(Date:12/17/2014)... 17, 2014 Based on the ... surgical imaging market is dominated by four major ... imaging market. These players include GE Healthcare (U.K.), ... (Germany). , Full Report Copy at ... Healthcare can be attributed to its strong product ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytic ... next step in its expanded strategy to rebuild the ... naming of current Chief Operating Officer, Valerie Palmieri ... Chairman of the Board and CEO James LaFrance ... are effective January 1, 2015. "Jim and ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4